Article
Parasite and host kinases as targets for antimalarials
1 Feb 2023
Abstract excerpt
Introduction The deployment of Artemisinin-based combination therapies and transmission control measures led to a decrease in the global malaria burden over the recent decades. Unfortunately, this trend is now reversing, in part due to resistance against available treatments, calling for the development of new drugs against untapped targets to prevent cross-resistance.Areas covered In view of their demonstrated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
